Factors influencing the magnitude, duration, and rate of fall of B-cell function in Type 1 (insulin-dependent) diabetic children followed for two years from their clinical diagnosis

Diabetologia

Volumn 31, Issue 9, 1988, Pages 664-669

  Wallensteen, M ^a   Dahlquist, G ^b   Persson, B ^a   Landin Olsson, M ^c   Lernmark, A ^c   Sundkvist, G ^c   Thalme, B ^d  

^a ST GÖRAN S HOSPITAL   (Sweden)

^b SACHS CHILDREN S HOSPITAL   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

C peptide; Children; insulin antibodies; islet cell antibodies; Type 1 (insulin dependent) diabetes

Indexed keywords

C PEPTIDE; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY;

ADOLESCENT; CHILD; CLINICAL ARTICLE; HUMAN; HUMAN EXPERIMENT; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PLASMA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; URINARY EXCRETION;

ADOLESCENT; C-PEPTIDE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, INSULIN-DEPENDENT; EATING; FASTING; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMAN; INFANT; INSULIN ANTIBODIES; ISLETS OF LANGERHANS; MALE; SUPPORT, NON-U.S. GOV'T;

EID: 0023750455     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/BF00278749     Document Type: Article

References (33)

1. Islet cell survival determined by morphology. An immunocytochemical study of the Islets of Langerhans in juvenile diabetes mellitus
2. The pancreas in recent onset Type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and other associated changes in the exocrine acinar tissue
3. Beta-cell function in children with diabetes
4. Evidence of delayed B-cell destruction in Type 1 (insulin-dependent) diabetic patients with persisting complement-fixing cytoplasmic islet cell antibodies
5. Natural course of insulin resistance in Type 1 diabetes
6. B-cell function recovery is not the only factor responsible for remission in Type 1 diabetics: evaluation of C-peptide secretion in diabetic children after first metabolic recompensation and at partial remission phase
7. Postinitial remission in diabetic children — an analysis of 178 cases
8. Remission phase, endogenous insulin secretion and metabolic control in diabetic children
9. Residual beta cell function and islet cell antibodies in diabetic children
10. Residual insulin secretion in insulin dependent diabetes mellitus
11. Islet-cell antibodies in diabetes mellitus
12. Islet-cell-surface antibodies in juvenile diabetes mellitus
13. Insulin antibodies in insulin dependent diabetes before insulin treatment
14. Increased reduction in fasting C-peptide is associated with islet cell antibodies in Type 1 (insulin-dependent) diabetes mellitus
15. Insulin antibodies in diabetic children treated with monocomponent porcine insulin from the onset: relationship to B-cell function and partial remission
16. Correlates of insulin antibodies in newly diagnosed children with insulin-dependent diabetes before insulin therapy
17. Relation between insulin antibody and complement-fixing islet cell antibody at clinical diagnosis of IDDM
18. The urinary C-peptide excretion in normal healthy children
19. Radioimmunological determination of human C-peptide in serum
20. Simplified determination of hemoglobin A1c in diabetic patients by use of electrofocusing
21. Determination of plasma acetoacetate and D-beta-hydroxybutyrate in newborn infants by an enzymatic fluorometric micromethod
22. Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and litres of islet cell antibodies in Type 1 (insulin-dependent) diabetes mellitus
23. Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies
24. Radioimmunoelectrophoresis in the determination of Insulin binding to IgG. Methodological studies
25. Factors affecting and patterns of residual insulin secretion during the first year of Type 1 (insulin-dependent) diabetes mellitus in children
26. Plasma C-peptide and insulin in neonates, infants and children
27. Impaired insulin action in puberty, a contributing factor to poor glycemic control in adolescents with diabetes
28. Glucose induced insulin response and insulin sensitivity is not related to HLA-type but to age in young siblings of Type 1 (insulin-dependent) diabetic patients
29. Effects of age, duration and treatment of insulin dependent diabetes mellitus on residual β-cell function: observations during eligibility testing for the diabetes control and complications trial (DCCT)
30. Islet cell and insulin autoantibodies in organspecific autoimmune patients. Their behaviour and predictive value for the development of Type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study
31. Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes
32. Kinetics of circulating endogenous insulin, C-peptide and proinsulin in fasting nondiabetic man
33. Increased kidney size and glomerular filtration rate in untreated juvenile diabetes: Normalization by insulin-treatment